Simon Englund
6PUBLICATIONS
6CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Nov 20, 2025
Use of Symptomatic Drug Treatment for Fatigue in Multiple Sclerosis and Patterns of Work Loss.Simon Englund, Johan Reutfors, Thomas Frisell
|Jun 26, 2024
COMBAT-MS: A Population-Based Observational Cohort Study Addressing the Benefit-Risk Balance of Multiple Sclerosis Therapies Compared with Rituximab.Fredrik Piehl, Peter Alping, Suvi Virtanen
|May 14, 2024
Trajectories of self-reported fatigue following initiation of multiple sclerosis disease-modifying therapy.Simon Englund, Thomas Frisell, Ying Qu
|Apr 19, 2023
Multiple sclerosis, disease-modifying drugs and risk for adverse perinatal and pregnancy outcomes: Results from a population-based cohort study.Katharina Fink, Agnes Gorczyca, Peter Alping
|Aug 22, 2022
COVID-19 clinical outcomes and DMT of MS patients and population-based controls.Elisa Longinetti, Hannah Bower, Kyla A McKay
|Jul 15, 2021
Risk of depression in multiple sclerosis across disease-modifying therapies.Elisa Longinetti, Thomas Frisell, Simon Englund
Pageof 1
